Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Filament Health N.FH

Alternate Symbol(s):  FLHLF

Filament Health Corp is a natural psychedelic drug discovery and extraction technology company. The company's mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. Filament engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NEO:FH)

Fundamentals Snapshot (NEO:FH)

Bullboard Posts (NEO:FH)

RE:Hi

is it me your looking for
younginvestor27 - April 16, 2022

Safe, Natural Psychedelics play worth watching

https://stockhouse.com/opinion/interviews/2022/04/12/unlocking-healing-potential-safe-natural-psychedelics
SHeditorial - April 13, 2022

APPROVAL FOR PHASE II CLINICAL TRIAL FOR DEPRESSION

Trial to investigate the effects of Filament's botanical psilocybin drug candidate and Cybin Therapeutics' protocols in...
Betteryear2 - January 31, 2022

The Power Play by The Market Herald Releases New Interviews

Filament Health has received FDA authorization to initiate the first clinical trial using naturally sourced psychedelic substances. The...
Betteryear2 - November 3, 2021

Files 20th Patent Application

Filament has been issued the first patent for the extraction and standardization of natural psilocybin and intends to further develop...
Betteryear2 - September 1, 2021

Industry-First Export of Natural GMP Psychedelics to US

The export to the Translational Psychedelic Research Program at UCSF represents an important step in advancing clinical research on...
Betteryear2 - August 26, 2021